Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review.
BACKGROUND: Pioglitazone has better cardiovascular outcomes and a questionable relationship with bladder carcinoma in diabetes mellitus, type II (DM-2). We sought to evaluate the role of pioglitazone in the Indian population. METHODS: This is a retrospect..... Read More